| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
small nucleolar RNA, C/D box 50A |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | |||||||||||
|
G protein-coupled receptor 75 | 1.000 | 0.038 | 1.6E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
androgen receptor regulated long noncoding RNA 1 | 0.890 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
TBC1 domain family member 3G | 0.931 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | |||||||||
|
macrophage stimulating 1 pseudogene | 1.000 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
prostate cancer expressed EZH2 associated transcript | 0.890 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
prostate enriched lncRNA | 0.931 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
immunoglobulin superfamily member 5 | 1.000 | 0.077 | 3.6E-17 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
transmembrane protein 64 | 0.931 | 0.077 | 0.49 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
spermatogenesis associated 19 | 0.839 | 0.077 | 3.5E-08 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
adenosylhomocysteinase like 2 | 0.931 | 0.077 | 0.99 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
high mobility group nucleosomal binding domain 2 pseudogene 46 | 0.890 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
integrator complex subunit 6 pseudogene 1 | 1.000 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
Sp5 transcription factor | 1.000 | 0.077 | 0.52 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
TBC1 domain family member 3B | 0.931 | 0.077 | 0.22 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
TBC1 domain family member 3C | 0.931 | 0.077 | 2.5E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
riboflavin kinase | 1.000 | 0.077 | 6.4E-02 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
NIPA like domain containing 3 | 1.000 | 0.077 | 7.0E-05 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
ectonucleotide pyrophosphatase/phosphodiesterase family member 5 | 1.000 | 0.077 | 3.2E-10 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
N-deacetylase and N-sulfotransferase 2 | 1.000 | 0.077 | 0.13 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
beta-1,4-galactosyltransferase 4 | 1.000 | 0.077 | 5.8E-07 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
anoctamin 7 | 0.839 | 0.115 | 3.5E-42 |
|
group | 0.030 | None | 0.667 | 3 | 1 | 2004 | 2018 | ||||||||
|
tudor domain containing 1 | 0.792 | 0.115 | 1.00 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2016 | ||||||||
|
TBC1 domain family member 3 | 0.861 | 0.115 | 0.53 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2006 | ||||||||
|
target of myb1 like 1 membrane trafficking protein | 0.890 | 0.115 | 4.6E-10 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 |